Jennison Associates’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-985,072
| Closed | -$14.5M | – | 685 |
|
|
2021
Q4 | $14.5M | Sell |
985,072
-14,804
| -1% | -$218K | 0.01% | 411 |
|
|
2021
Q3 | $20.9M | Buy |
999,876
+2,931
| +0.3% | +$61.3K | 0.01% | 358 |
|
|
2021
Q2 | $17.6M | Sell |
996,945
-146,534
| -13% | -$2.59M | 0.01% | 387 |
|
|
2021
Q1 | $28M | Buy |
1,143,479
+619,999
| +118% | +$15.2M | 0.02% | 307 |
|
|
2020
Q4 | $17.7M | Buy |
523,480
+372,879
| +248% | +$12.6M | 0.01% | 348 |
|
|
2020
Q3 | $3.77M | Buy |
150,601
+543
| +0.4% | +$13.6K | ﹤0.01% | 452 |
|
|
2020
Q2 | $5.06M | Buy |
+150,058
| New | +$5.06M | ﹤0.01% | 427 |
|